Drug resistance in pancreatic cancer: New player caught in act

EBioMedicine. 2019 Feb:40:39-40. doi: 10.1016/j.ebiom.2019.02.008. Epub 2019 Feb 11.

Authors

Gabriele Capurso¹, Claudio Sette²

Affiliations

¹ PancreatoBiliary Endoscopy and EUS Division, Pancreas Translational and Clinical Research Center, San Raffaele Scientific Institute IRCCS, Milan, Italy.
² Institute of Human Anatomy and Cell Biology, Università Cattolica del Sacro Cuore, Rome, Italy; IRCCS Fondazione Santa Lucia, Rome, Italy. Electronic address: claudio.sette@unicatt.it.

No abstract available

Publication types

Letter

MeSH terms

Antineoplastic Agents / pharmacology
Antineoplastic Agents / therapeutic use*
Drug Resistance, Neoplasm*
Humans
Pancreatic Neoplasms / drug therapy*
Pancreatic Neoplasms / mortality
Pancreatic Neoplasms / pathology
Prognosis
Tumor Microenvironment

Substances

Antineoplastic Agents